Cargando…

Does hyperoxia enhance susceptibility to secondary pulmonary infection in the ICU?

Hyperoxia is common practice in the acute management of circulatory shock, and observational studies report that it is present in more than 50 % of mechanically ventilated patients during the first 24 h after intensive care unit (ICU) admission. On the other hand, “oxygen toxicity” due to the increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nußbaum, Benedikt, Radermacher, Peter, Asfar, Pierre, Hartmann, Clair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986255/ https://www.ncbi.nlm.nih.gov/pubmed/27526848 http://dx.doi.org/10.1186/s13054-016-1427-x

Ejemplares similares

Before the ICU: does emergency room hyperoxia affect outcome?
por: Wepler, Martin, et al.
Publicado: (2018)

Cardiac surgery, a right target for hyperoxia?
por: Boisramé-Helms, Julie, et al.
Publicado: (2016)

Dangers of hyperoxia
por: Singer, Mervyn, et al.
Publicado: (2021)

Hyperoxia toxicity in septic shock patients according to the Sepsis-3 criteria: a post hoc analysis of the HYPER2S trial
por: Demiselle, Julien, et al.
Publicado: (2018)

Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?
por: Asfar, Pierre, et al.
Publicado: (2009)

Hyperoxia in intensive care, emergency, and peri-operative medicine: Dr. Jekyll or Mr. Hyde? A 2015 update
por: Hafner, Sebastian, et al.
Publicado: (2015)

Is pharmacological, H(2)S-induced 'suspended animation' feasible in the ICU?
por: Asfar, Pierre, et al.
Publicado: (2014)

Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?
por: Bracht, Hendrik, et al.
Publicado: (2007)

Target blood pressure in sepsis: between a rock and a hard place
por: Beloncle, François, et al.
Publicado: (2013)

Gaseous Mediators and Mitochondrial Function: The Future of Pharmacologically Induced Suspended Animation?
por: Hartmann, Clair, et al.
Publicado: (2017)

Ethyl pyruvate for the treatment of acetaminophen intoxication: alternative to N-acetylcysteine?
por: Wagner, Florian, et al.
Publicado: (2012)

Vasopressin in vasodilatory shock: is the heart in danger?
por: Hauser, Balázs, et al.
Publicado: (2008)

Of mice and men (and sheep, swine etc.): The intriguing hemodynamic and metabolic effects of hydrogen sulfide (H(2)S)
por: Wagner, Katja, et al.
Publicado: (2011)

Paper reports overview: Avoiding secondary insults in ICU
por: Steele, Adrian
Publicado: (2000)

Eubaric hyperoxia: controversies in the management of acute traumatic brain injury
por: Narotam, Pradeep K
Publicado: (2013)

Does vasopressor therapy have an indication in hemorrhagic shock?
por: Beloncle, François, et al.
Publicado: (2013)

Hyperoxia after cardiac arrest may not increase ischemia-reperfusion injury
por: Hoedemaekers, Cornelia W, et al.
Publicado: (2011)

Target arterial PO(2) according to the underlying pathology: a mini-review of the available data in mechanically ventilated patients
por: Demiselle, Julien, et al.
Publicado: (2021)

Hyperoxia post cardiac arrest: experience of a UK ICU
por: Tameem, L, et al.
Publicado: (2011)

Pulmonary and renal protection: targeting PARP to ventilator-induced lung and kidney injury?
por: Matejovic, Martin, et al.
Publicado: (2010)

Pulmonary response to hyperoxia: effects of magnesium.
por: Dedhia, H V, et al.
Publicado: (1994)

Hyperoxia Alters Ultrastructure and Induces Apoptosis in Leukemia Cell Lines
por: De Bels, David, et al.
Publicado: (2020)

Does the hygiene hypothesis apply to COVID-19 susceptibility?
por: Sehrawat, Sharvan, et al.
Publicado: (2020)

Does UCP2 Couple Hyperoxia to Lung Injury?
por: Larson-Casey, Jennifer L., et al.
Publicado: (2021)

Endotracheal intubation in the ICU
por: Lapinsky, Stephen E.
Publicado: (2015)

Coming soon to an ICU near you: severe pandemic influenza in ICU patients in Spain
por: Opal, Steven M
Publicado: (2009)

ICU Cornerstone: High frequency ventilation is here to stay
por: Rimensberger, Peter C
Publicado: (2003)

Poly I:C Enhances Susceptibility to Secondary Pulmonary Infections by Gram-Positive Bacteria
por: Tian, Xiaoli, et al.
Publicado: (2012)

Utile or futile: biomarkers in the ICU
por: Balmelli, Cathrin, et al.
Publicado: (2011)

Interfacing the ICU with the general practitioner
por: Girbes, Armand RJ, et al.
Publicado: (2010)

Continuing HIV therapy in the ICU
por: Soni, Neil, et al.
Publicado: (2001)

ICU cornerstone: 'triggering effort'
por: Fernandez, Rafael
Publicado: (2003)

The obesity paradox in the ICU: real or not?
por: Dickerson, Roland N
Publicado: (2013)

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?
por: Beer, Karlyn D., et al.
Publicado: (2020)

The Unrecognized Threat of Secondary Bacterial Infections with COVID-19
por: Vaillancourt, Mylene, et al.
Publicado: (2020)

Omeprazole does not Potentiate Acute Oxygen Toxicity in Fetal Human Pulmonary Microvascular Endothelial Cells Exposed to Hyperoxia
por: Patel, Ananddeep, et al.
Publicado: (2015)

Wireless technology in the ICU: boon or ban?
por: Gladman, Aviv S, et al.
Publicado: (2007)

Weakness in the ICU: a call to action
por: Stevens, Robert D, et al.
Publicado: (2009)

Patients with cancer on the ICU: the times they are changing
por: de Jonge, Evert, et al.
Publicado: (2009)

The role of inflammation in ICU-acquired weakness
por: Winkelman, Chris
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gljj7617lfufpgq2ih813j7stj